The use of direct oral anticoagulants (DOAC) in the treatment atrial fibrillation (AF) patients
Lehto, M.; Mustonen, P.; Tierala, I.
Duodecim; Laaketieteellinen Aikakauskirja 130(17): 1709-1717
2014
ISSN/ISBN: 0012-7183 PMID: 25272782 Document Number: 671943
AF is associated with the risk of stroke, and this risk is exceedingly high in elderly patients (> or = 75 years) and in patients after a stroke. DOACs are appropriate anticoagulants for AF patients without mechanical heart valves or mitral stenosis. Patients on DOACs do not require routine monitoring of coagulation, but need regular follow-up visits including an assessment of therapy adherence, thromboembolic and bleeding events and measurements of hemoglobin and platelets values as well as renal and liver function.
Document emailed within 1 workday
Related Documents
Scanziani, R.; Galassi, A. 2010: Treatment of atrial fibrillation in dialyzed patients: the role of oral anticoagulants. the nephrologist's point of view Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 27(3): 230-236Zotova, I.V.; Zateĭshchikov, D.A. 2011: Risk and benefit of oral anticoagulants in atrial fibrillation Kardiologiia 51(10): 81-91
Tu, R-Hui.; Zhong, G-Qiang.; Zeng, Z-Yu.; Wu, W-Feng.; He, Y. 2011: A meta-analysis on efficacy of anti-platelet agents and anticoagulants for preventing stroke in patients with nonvalvular atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 39(3): 262-267
Setiabudi, E.; Alwi, I.; Setiati, S. 2008: Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental? Acta Medica Indonesiana 40(1): 40-47
Stebler-Fontaine, L.; Rossel, A.; Marti, C.; Righini, M.; Robert-Ebadi, H. 2019: Direct oral anticoagulants in the treatment of cancer-associated thrombosis Revue Medicale Suisse 15(674): 2232-2235
Cox, J.L.; Schuessler, R.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 402-405
Banasiak, W.; Telichowski, C.; Pertuk, J.; Metner, E.; Góral, J.; Zebrowski, J. 1988: Indirect and direct measurements of arterial pressure in patients with atrial fibrillation Wiadomosci Lekarskie 41(19): 1265-1270
Gurciková, M.; Kaluzay, J.; Remisová, S.; Jurkovicová, O.; Pontuch, P. 2008: Late recurrences of atrial fibrillation in patients after direct-current cardioversion Vnitrni Lekarstvi 54(6): 604-608
Van Gennip, A.; Hellemons-Boode, B.; Krebber, T.; Langenberg-Ledeboer, M. 1992: Anticoagulants in non-rheumatic atrial fibrillation Nederlands Tijdschrift Voor Geneeskunde 136(4): 195-196
Forslund, T.; von Euler, M.; Johnsson, H.; Holmström, M.; Wettermark, B.ör.; Hjemdahl, P. 2015: More with atrial fibrillation, anticoagulants since the coming of NOAK Lakartidningen 112
Cox, J.L.; Canavan, T.E.; Schuessler, R.B.; Cain, M.E.; Lindsay, B.D.; Stone, C.; Smith, P.K.; Corr, P.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 406-426
Wu, G.; Jiang, H.; Huang, C.-x.; Yang, B.; Huang, H.; Wang, Y.-l.; Wang, X.-h.; Liu, H.-f.; Yang, X.-h. 2008: Effects of antiarrhythmic drug use on atrial fibrillation recurrence in atrial fibrillation patients post circumferential pulmonary vein ablation Zhonghua Xin Xue Guan Bing Za Zhi 36(7): 623-626
Carlsäter, J.; Kristjansson, G.; Nilsson, G. 1994: Anticoagulants in non-valvular atrial fibrillation. a clinical dilemma in practice Lakartidningen 91(35): 3053-3056
Wen, S.; Liu, N.; Li, S.; Ning, M.; Kang, J.; Wu, J.; Ruan, Y.; Jiang, C.; Sang, C.; Tang, R.; Long, D.; Yu, R.; Bai, R.; Du, X.; Hu, R.; Dong, J.; Liu, X.; Ma, C. 2015: Predictors of atrial fibrillation recurrence after catheter ablation in hypertrophic cardiomyopathy patients with atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 43(7): 589-594
Le Mao, R.ël.; Tromeur, C.éc.; Fofana, A.; Leroyer, C.; Lacut, K. 2018: Direct oral anticoagulants La Revue du Praticien 68(5): 475-482
Charantharayil Gopalan, B.; Namboodiri, N.; Abdullakutty, J.; Lip, G.Y.; Koshy, A.G.; Krishnan Nair, V.; Babu, S.; Muhammed, S.; Azariah, J.L.; George, R.; Nambiar, A.; Govindan, U.; Zachariah, G.; Kumaraswamy, N.; Chakanalil Govindan, S.; Natesan, S.; Roby, A.; Velayudhan Nair, K.; Pillai, A.M.; Daniel, R.; Jayagopal, P.B.; Punnose, E.; Joseph, J.; Joseph, S.; Eapen, K.; Ram, R.; Mathew, C.; Faizal, A.; Issac, B.; Renga, S.; Menon, J.; Harikrishna, D.; Suresh, K.; Nair, T.; Susanth, S.S.; Kumar, R.A.; Abilash, T.P.; Sreekala, P.; Rajeev, E.; Raj, A.; Naik, R.; Rajalekshmi; Gopinath, A.; Binu, R.; Chacko, J.; Iqbal, P.T.; Sudhir, N.M.; Sreedharan, M.; Balakrishnan, N.; Musthaffa, M.; Jayakumar, B.; George, S.; Kumar, A.; Mathew, T.; Pramod, 2019: Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile Bmj Open 9(7): E025901
Petri, H.; Kafka, W.; Rudolph, W. 1983: Discrepant effects of oral and intravenous verapamil on A-V conduction in patients with ventricular preexcitation and atrial fibrillation Herz 8(3): 144-152
Manoharan, S.; Kaul, U.A.; Khalilullah, M. 1986: Effectiveness of oral verapamil in controlling ventricular rate in patients with chronic atrial fibrillation receiving digoxin Journal of the Association of Physicians of India 34(4): 257-259
Bellandi, F.; Cantini, F.; Pedone, T.; Dabizzi, R.P.; Palchetti, R. 1993: The efficacy of intravenous propafenone and amiodarone in the conversion of recent-onset atrial fibrillation. a 1-year follow-up with oral treatment Giornale Italiano di Cardiologia 23(3): 261-271
Ertas, F.; Oylumlu, M.; Akil, M.A.; Acet, H.; Bilik, M.Z.; Celepkolu, T.; Yildiz, A.; Kaya, H.; Alan, S.; Ozhan, H. 2013: Non-valvular atrial fibrillation in the elderly; preliminary results from the National AFTER (Atrial Fibrillation in Turkey: Epidemiologic Registry) Study European Review for Medical and Pharmacological Sciences 17(8): 1012-1016